Secondary Logo

Journal Logo

AAPA Members can view Full text articles for FREE. Not a Member? Join today!

Institutional members access full text with Ovid®

Beyond the PSA test

How to better stratify a patient's risk of prostate cancer

Lewis, Ryan PA-C; Hornberger, Brad PA-C

Journal of the American Academy of PAs: August 2017 - Volume 30 - Issue 8 - p 51–54
doi: 10.1097/01.JAA.0000521148.78442.d5
Special Topics in Urology
Buy

ABSTRACT The primary method of screening for and detecting prostate cancer is the prostate-specific antigen (PSA) test. Although this test is very prostate-specific, it is not cancer-specific; conditions other than prostate cancer can cause an elevated PSA. Many efforts have been made to discover more specific tests and methods beyond the PSA. This article describes several literature-supported tests and methods to better stratify a man's risk of having prostate cancer.

At the time this article was written, Ryan Lewis is a urology fellow at the University of Texas Southwestern Medical Center in Dallas, Tex. Brad Hornberger is a faculty associate and program director of the PA postgraduate urology training program at the University of Texas Southwestern Medical Center. The authors have disclosed no potential conflicts of interest, financial or otherwise.

Roy A. Borchardt, PA-C, PhD, and Michael D. Overcash, MPAS, PA-C, department editors

Copyright © 2017 American Academy of Physician Assistants
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website